Constance Benson, MD, an internationally recognized researcher and clinician working in the fields of HIV and TB clinical and translational investigation, has joined NDA Partners as an expert consultant. Dr. Benson is a Professor of Medicine and Global Public Health, Senior Attending Physician, and the Vice Chair for Education and ID Training Program Director for the Division of Infectious Diseases and Global Public Health at University of California, San Diego (UCSD). She is also Director of the UCSD Antiviral Research Unit (AVRC), the Principal Investigator of the UCSD CD4 Collaborative HIV Clinical Trials Unit (CTU), and the Clinical Research Site (CRS) Leader for the UCSD AVRC HIV Clinical Research Site.
Dr. Benson served as the Chair of the Scientific Agenda Steering Committee, Principal Investigator, and Chair of the Executive Committee of the National Institutes of Health/National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group (ACTG) Network. In addition, she was formerly Chair of the National Institutes of Health (NIH) Office of AIDS Research Advisory Council (OARAC), and she has served on numerous NIH ad hoc study sections, on the Scientific Program Committees for the Infectious Disease Society of America (IDSA), the Conference on Retroviruses and Opportunistic Infections (CROI), the International AIDS Society (IAS), and on the Board of Directors of the International Antiviral Society-USA.
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.Source: Virtual Strategy